{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:25:26Z","timestamp":1772112326979,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.brachy.2025.11.006","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T21:01:38Z","timestamp":1765918898000},"page":"342-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dosimetric impact of androgen deprivation therapy (ADT)-induced prostate deformation in low-dose-rate prostate brachytherapy"],"prefix":"10.1016","volume":"25","author":[{"given":"Younghun","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wooshik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7296-8983","authenticated-orcid":false,"given":"Han-Back","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4856-6305","authenticated-orcid":false,"given":"Jihun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9966-5157","authenticated-orcid":false,"given":"Jaeho","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.brachy.2025.11.006_bib0001","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2011.10827.x","article-title":"Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. results from the prostate cancer results study group","volume":"109","author":"Grimm","year":"2012","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.brachy.2025.11.006_bib0002","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.prnil.2023.01.004","article-title":"The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer","volume":"11","author":"Tanaka","year":"2023","journal-title":"Prostate Int"},{"issue":"5","key":"10.1016\/j.brachy.2025.11.006_bib0003","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ijrobp.2010.04.038","article-title":"10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1100 patients","volume":"80","author":"Crook","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.brachy.2025.11.006_bib0004","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrurol.2017.76","article-title":"The evolution of brachytherapy for prostate cancer","volume":"14","author":"Zaorsky","year":"2017","journal-title":"Nat Rev Urol"},{"issue":"2","key":"10.1016\/j.brachy.2025.11.006_bib0005","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.294.2.238","article-title":"Androgen deprivation therapy for prostate cancer","volume":"294","author":"Sharifi","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.brachy.2025.11.006_bib0006","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.brachy.2017.08.003","article-title":"High-intermediate prostate cancer treated with low-dose-rate brachytherapy with or without androgen deprivation therapy","volume":"16","author":"Pickles","year":"2017","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.brachy.2025.11.006_bib0007","doi-asserted-by":"crossref","first-page":"378","DOI":"10.21037\/tau.2018.01.06","article-title":"Adjuvant androgen deprivation therapy for prostate cancer treated with radiation therapy","volume":"7","author":"Siddiqui","year":"2018","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.brachy.2025.11.006_bib0008","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.urolonc.2009.03.024","article-title":"Neoadjuvant androgen deprivation for prostate volume reduction: the optimal duration in prostate cancer radiotherapy","volume":"29","author":"Langenhuijsen","year":"2011","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2025.11.006_bib0009","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/luts.12142","article-title":"Impact of androgen deprivation therapy on volume reduction and lower urinary tract symptoms in patients with prostate cancer","volume":"10","author":"Washino","year":"2018","journal-title":"Low Urin Tract Symptoms"},{"issue":"2","key":"10.1016\/j.brachy.2025.11.006_bib0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1148\/radiology.218.2.r01ja04365","article-title":"Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging","volume":"218","author":"Padhani","year":"2001","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.brachy.2025.11.006_bib0011","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/1097-0142(19881201)62:11<2325::AID-CNCR2820621112>3.0.CO;2-S","article-title":"Kinetic analysis of prostatic volume in treating prostatic cancer and its predictability for prognosis","volume":"62","author":"Ohe","year":"1988","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.brachy.2025.11.006_bib0012","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-8140(03)00031-8","article-title":"Neoadjuvant androgen deprivation and prostate gland shrinkage during conformal radiotherapy","volume":"66","author":"Sanguineti","year":"2003","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.brachy.2025.11.006_bib0013","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0360-3016(95)02064-0","article-title":"The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer","volume":"33","author":"Yang","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.brachy.2025.11.006_bib0014","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0360-3016(94)90563-0","article-title":"Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy","volume":"29","author":"Zelefsky","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.brachy.2025.11.006_bib0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.brachy.2017.11.007","article-title":"Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: results of a prospective phase II study","volume":"17","author":"Blanchard","year":"2018","journal-title":"Brachytherapy"},{"issue":"5","key":"10.1016\/j.brachy.2025.11.006_bib0016","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/jrr\/rrae056","article-title":"Impact of neoadjuvant androgen deprivation therapy on toxicity in intensity-modulated radiation therapy for prostate cancer","volume":"65","author":"Serizawa","year":"2024","journal-title":"J Radiat Res"},{"issue":"5","key":"10.1016\/j.brachy.2025.11.006_bib0017","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5114\/jcb.2016.63377","article-title":"Predictors of prostate volume reduction following neoadjuvant cytoreductive androgen suppression","volume":"8","author":"Jethwa","year":"2016","journal-title":"J Contemp Brachytherapy"},{"issue":"4","key":"10.1016\/j.brachy.2025.11.006_bib0018","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1088\/0031-9155\/56\/4\/011","article-title":"A population-based model to describe geometrical uncertainties in radiotherapy: applied to prostate cases","volume":"56","author":"Budiarto","year":"2011","journal-title":"Phys Med Biol"},{"issue":"1","key":"10.1016\/j.brachy.2025.11.006_bib0019","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1109\/TMI.2009.2035616","article-title":"Elastix: a toolbox for intensity-based medical image registration","volume":"29","author":"Klein","year":"2010","journal-title":"IEEE Trans Med Imaging"},{"issue":"8","key":"10.1016\/j.brachy.2025.11.006_bib0020","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1109\/42.796284","article-title":"Nonrigid registration using free-form deformations: application to breast MR images","volume":"18","author":"Rueckert","year":"1999","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.brachy.2025.11.006_bib0021","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.media.2017.03.001","article-title":"Population model of bladder motion and deformation based on dominant eigenmodes and mixed-effects models in prostate cancer radiotherapy","volume":"38","author":"Rios","year":"2017","journal-title":"Med Image Anal"},{"issue":"9","key":"10.1016\/j.brachy.2025.11.006_bib0022","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1118\/1.3481506","article-title":"Optimizing principal component models for representing interfraction variation in lung cancer radiotherapy","volume":"37","author":"Badawi","year":"2010","journal-title":"Med Phys"},{"issue":"5","key":"10.1016\/j.brachy.2025.11.006_bib0023","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.brachy.2016.04.388","article-title":"Robustness to source displacement in dual air kerma strength planning for focal low-dose-rate brachytherapy of prostate cancer","volume":"15","author":"Mahdavi","year":"2016","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.brachy.2025.11.006_bib0024","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ijrobp.2014.06.040","article-title":"Statistical modeling of CTV motion and deformation for IMRT of early-stage rectal cancer","volume":"90","author":"Bondar","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.brachy.2025.11.006_bib0025","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.brachy.2016.07.004","article-title":"Stranded seed displacement, migration, and loss after permanent prostate brachytherapy as estimated by Day 0 fluoroscopy and 4-month postimplant pelvic x-ray","volume":"15","author":"Birckhead","year":"2016","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.brachy.2025.11.006_bib0026","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13014-020-1482-y","article-title":"Accuracy of automatic deformable structure propagation for high-field MRI guided prostate radiotherapy","volume":"15","author":"Christiansen","year":"2020","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.brachy.2025.11.006_bib0027","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/mp.17000","article-title":"Deep-learning-based joint rigid and deformable contour propagation for magnetic resonance imaging-guided prostate radiotherapy","volume":"51","author":"Kolenbrander","year":"2024","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.brachy.2025.11.006_bib0028","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55317-1","article-title":"New sparse implantation technique of I-125 low-dose-rate brachytherapy using concomitant short-term hormonal treatment for low and intermediate-risk prostate cancer: an initial study of therapeutic feasibility","volume":"9","author":"Yu","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.brachy.2025.11.006_bib0029","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.radonc.2007.07.014","article-title":"Evaluation of source displacement and dose\u2013volume changes after permanent prostate brachytherapy with stranded seeds","volume":"84","author":"Pinkawa","year":"2007","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2025.11.006_bib0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijrobp.2016.04.015","article-title":"Edema and seed displacements affect intraoperative permanent prostate brachytherapy dosimetry","volume":"96","author":"Westendorp","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:40:54Z","timestamp":1772109654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125003642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1538472125003642"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2025.11.006","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric impact of androgen deprivation therapy (ADT)-induced prostate deformation in low-dose-rate prostate brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2025.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}